Reactive Nitrogen Species Induce Nuclear Factor-kappaB-mediated Protein Degradation in Skeletal Muscle Cells
Overview
Biology
General Medicine
Authors
Affiliations
Recently, a role for NF-kappaB in upregulation of proteolytic systems and protein degradation has emerged. Reactive nitrogen species (RNS) have been demonstrated to induce NF-kappaB activation. The aim of this study was to investigate whether RNS caused increased proteolysis in skeletal muscle cells, and whether this process was mediated through the activation of NF-kappaB. Fully differentiated L6 myotubes were treated with NO donor SNAP, peroxynitrite donor SIN-1, and authentic peroxynitrite, in a time-dependent manner. NF-kappaB activation, the activation of the ubiquitin-proteasome pathway and matrix metalloproteinases, and the levels of muscle-specific proteins (myosin heavy chain and telethonin) were investigated under the conditions of nitrosative stress. RNS donors caused NF-kappaB activation and increased activation of proteolytic systems, as well as the degradation of muscle-specific proteins. Antioxidant treatment, tyrosine nitration inhibition, and NF-kappaB molecular inhibition were proven effective in downregulation of NF-kappaB activation and slowing down the degradation of muscle-specific proteins. Peroxynitrite, but not NO, causes proteolytic system activation and the degradation of muscle-specific proteins in cultured myotubes, mediated through NF-kappaB. NF-kappaB inhibition by antioxidants, tyrosine nitration, and molecular inhibitors may be beneficial for decreasing the extent of muscle damage induced by RNS.
Type 2 diabetes-related sarcopenia: role of nitric oxide.
Bahadoran Z, Mirmiran P, Ghasemi A Nutr Metab (Lond). 2024; 21(1):107.
PMID: 39695784 PMC: 11656607. DOI: 10.1186/s12986-024-00883-z.
Cerrone Jr J, Lee C, Mi T, Morgan E Drug Metab Dispos. 2020; 48(7):544-552.
PMID: 32350062 PMC: 7289052. DOI: 10.1124/dmd.119.089961.
Nitroxidized-Albumin Advanced Glycation End Product and Rheumatoid Arthritis.
Tarannum A, Arif Z, Alam K, Ahmad S, Uddin M Arch Rheumatol. 2020; 34(4):461-475.
PMID: 32010898 PMC: 6974383. DOI: 10.5606/ArchRheumatol.2019.7285.
Abdul Nasir N, Agarwal R, Sheikh Abdul Kadir S, Vasudevan S, Tripathy M, Iezhitsa I PLoS One. 2017; 12(3):e0174542.
PMID: 28350848 PMC: 5370128. DOI: 10.1371/journal.pone.0174542.
Vitamin E in sarcopenia: current evidences on its role in prevention and treatment.
Khor S, Abdul Karim N, Wan Ngah W, Mohd Yusof Y, Makpol S Oxid Med Cell Longev. 2014; 2014:914853.
PMID: 25097722 PMC: 4109111. DOI: 10.1155/2014/914853.